Hillemacher T

Department of Psychiatry and Psychotherapy, Paracelsus Medical University Nuremberg, Nürnberg, Germany.

1 paper

ArticlePsilocybin

Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder.

Köhne S, Hillemacher T, Glahn A +1